4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-26-035039
Director sold 4,090 shares at an average $70.92 ($290,062)
- Director acquired 4,090 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tsuchimoto Kim R · Director
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,199 | $30.00 | $35,970 | 1,199 | D |
| 2026-11-02 | Sale : show line 2 in the form 10b5-1 | −1,199 | $70.10 | $84,050 | 0 | D |
| 2026-11-04 | Exercise or conversion : show line 3 in the form 10b5-1 | +856 | $30.00 | $25,680 | 856 | D |
| 2026-11-04 | Exercise or conversion : show line 4 in the form 10b5-1 | +2,035 | $14.00 | $28,490 | 2,891 | D |
| 2026-11-04 | Sale : show line 5 in the form 10b5-1 | −1,295 | $70.75 | $91,621 | 1,596 | D |
| 2026-11-04 | Sale : show line 6 in the form 10b5-1 | −996 | $71.35 | $71,065 | 600 | D |
| 2026-11-04 | Sale : show line 7 in the form 10b5-1 | −600 | $72.21 | $43,326 | 0 | D |
| Open-market sales · 4,090 sh · avg $70.92 · $290,062 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option | −1,199 | 4,966 | D |
| 2026-11-04 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option | −856 | 4,110 | D |
| 2026-11-04 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option | −2,035 | 6,105 | D |
Loading xslF345X06/rdgdoc.xml…